Treatments | Method of application | Disease severity (%) |
---|---|---|
Bacillus amyloliquefaciens | Cell suspension | 26de |
Formulation | 19f | |
Bacillus subtilis | Cell suspension | 35c |
Formulation | 29d | |
Pseudomonas fluorescens | Cell suspension | 45b |
Formulation | 35c | |
Pseudomonas aeruginosa | Cell suspension | 30d |
Formulation | 25de | |
Control | Infected | 75a |
Healthy | 00 |